All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-YC0128 | Anti-EFNB2 (CBYCJ-022) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | CBYCJ-022 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0129 | Anti-EFNB2 (CBYCJ-023) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | CBYCJ-023 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC1028 | Anti-EFNB2 (CBYCJ-022) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | CBYCJ-022 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC1029 | Anti-EFNB2 (CBYCJ-023) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | CBYCJ-023 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
XS-1222-ZP67 | EFNB2 (EPHA6 Receptor) h(CD28-CD3ζ) Ligand-based CAR, pCDCAR1 | Human | EFNB2-CD28-CD6ζ | Lentiviral vector | T cell | ||||
XS-1222-ZP582 | EFNB2 (EPHA4 Receptor) h(CD28-CD3ζ) Ligand-based CAR, pCDCAR1 | Human | EFNB2-CD28-CD6ζ | Lentiviral vector | T cell | ||||
XS-1222-ZP583 | EFNB2 (EPHB1 Receptor) h(CD28-CD3ζ) Ligand-based CAR, pCDCAR1 | Human | EFNB2-CD28-CD6ζ | Lentiviral vector | T cell | ||||
XS-1222-ZP584 | EFNB2 (EPHB2 Receptor) h(CD28-CD3ζ) Ligand-based CAR, pCDCAR1 | Human | EFNB2-CD28-CD6ζ | Lentiviral vector | T cell | ||||
XS-1222-ZP585 | EFNB2 (EPHB3 Receptor) h(CD28-CD3ζ) Ligand-based CAR, pCDCAR1 | Human | EFNB2-CD28-CD6ζ | Lentiviral vector | T cell | ||||
XS-1222-ZP586 | EFNB2 (EPHB4 Receptor) h(CD28-CD3ζ) Ligand-based CAR, pCDCAR1 | Human | EFNB2-CD28-CD6ζ | Lentiviral vector | T cell | ||||
XS-1222-ZP587 | EFNB2 (EPHB6 Receptor) h(CD28-CD3ζ) Ligand-based CAR, pCDCAR1 | Human | EFNB2-CD28-CD6ζ | Lentiviral vector | T cell | ||||
XS-1222-ZP1467 | EFNB2 (EPHA6 Receptor) h(41BB-CD3ζ) Ligand-based CAR, pCDCAR1 | Human | EFNB2-41BB-CD6ζ | Lentiviral vector | T cell | ||||
XS-1222-ZP1982 | EFNB2 (EPHA4 Receptor) h(41BB-CD3ζ) Ligand-based CAR, pCDCAR1 | Human | EFNB2-41BB-CD6ζ | Lentiviral vector | T cell | ||||
XS-1222-ZP1983 | EFNB2 (EPHB1 Receptor) h(41BB-CD3ζ) Ligand-based CAR, pCDCAR1 | Human | EFNB2-41BB-CD6ζ | Lentiviral vector | T cell | ||||
XS-1222-ZP1984 | EFNB2 (EPHB2 Receptor) h(41BB-CD3ζ) Ligand-based CAR, pCDCAR1 | Human | EFNB2-41BB-CD6ζ | Lentiviral vector | T cell | ||||
XS-1222-ZP1985 | EFNB2 (EPHB3 Receptor) h(41BB-CD3ζ) Ligand-based CAR, pCDCAR1 | Human | EFNB2-41BB-CD6ζ | Lentiviral vector | T cell | ||||
XS-1222-ZP1986 | EFNB2 (EPHB4 Receptor) h(41BB-CD3ζ) Ligand-based CAR, pCDCAR1 | Human | EFNB2-41BB-CD6ζ | Lentiviral vector | T cell | ||||
XS-1222-ZP1987 | EFNB2 (EPHB6 Receptor) h(41BB-CD3ζ) Ligand-based CAR, pCDCAR1 | Human | EFNB2-41BB-CD6ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION